Point72 Hong Kong LTD Hookipa Pharma Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $11,440 - $19,870	-8,602 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $9,181 - $18,363	7,287 Added 554.14%	8,602 $20,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.94 $3,063 - $7,811	1,315 New	1,315 $3,000
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $9,376 - $14,885	-1,592 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $14,582 - $31,059	1,592 New	1,592 $15,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.